Cargando…
Corticosteroids for community-acquired pneumonia: time to act!
The use of corticosteroids for the treatment of community-acquired pneumonia has been reported for almost 50 years. A recent systematic analysis of the relevant literature suggested that corticosteroids reduce the critical illness associated with community-acquired pneumonia. There is little doubt t...
Autores principales: | Annane, Djillali, Meduri, G Umberto |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2008
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2575557/ https://www.ncbi.nlm.nih.gov/pubmed/18638361 http://dx.doi.org/10.1186/cc6940 |
Ejemplares similares
-
Corticosteroids for sepsis: registry versus Cochrane systematic review!
por: Annane, Djillali
Publicado: (2010) -
Prolonged corticosteroid treatment in acute respiratory distress syndrome: impact on mortality and ventilator-free days
por: Meduri, Gianfranco Umberto, et al.
Publicado: (2018) -
Corticosteroids in Community-Acquired Bacterial Pneumonia: a Systematic Review, Pairwise and Dose-Response Meta-Analysis
por: Pitre, Tyler, et al.
Publicado: (2023) -
Precision medicine for corticotherapy in COVID-19
por: Annane, Djillali, et al.
Publicado: (2022) -
Corticosteroids for COVID-19
por: Annane, Djillali
Publicado: (2021)